— Why it moved
Why MDXH Stock Spiked and Faded Today — August 14, 2026
MDxHealth reported earnings and disclosed a major shareholder stake, triggering a massive volume surge that ultimately trap-doored late chasers.
What moved MDXH stock
MDxHealth SA provides molecular diagnostic tests for prostate and kidney cancers. They posted Q2 revenue results alongside a Schedule 13D showing Bleichroeder LP took a 33.2% stake. While the headline sounded like a massive institutional vote of confidence, that stake was taken via a discounted direct offering at roughly 45 cents a share.
The mechanics
A $24M micro-cap carrying 41.5M float shares traded nearly 325M shares in a single session. That staggering turnover rate—almost eight times the float—proves retail algorithms were furiously churning the news before dilution reality set in.
MDXH by the numbers
The alert window
The signal flagged MDXH at $1.00 at 9:53 AM. Anyone jumping in blindly immediately took a 24.1% beating down to $0.7598 before the stock recovered. It took 98 minutes to scrape up to the $1.13 peak, offering a meager 12.9% max exit window that lasted less than an hour.
How MDXH's move ended
The move unraveled completely after midday, dumping to close at $0.8093 for a 19.2% loss against the alert price. Massive share issuance at $0.454 anchors long-term upside, leaving anyone holding above a dollar as exit liquidity.
The tell: A huge institutional stake filing looks bullish until you check the transaction price on the prospectus.